milrinone has been researched along with atrial natriuretic factor in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buchholz, RA; Pagani, ED; Silver, PJ | 1 |
| Mitrovic, V; Schlepper, M; Stöhring, R | 1 |
| Berglund, H; Bevegård, S; Carlens, P; Hedner, J; Hedner, T | 1 |
| Aardal, S; Helle, KB; Lillestłl, IK | 1 |
| Dohi, S; Fujiwara, H; Iida, H; Iida, M; Oda, A; Takenaka, M; Uchida, M | 1 |
| Herring, N; Paterson, DJ; Zaman, JA | 1 |
| Poole-Wilson, PA | 1 |
| Cho, KW; Cui, X; Jin, JY; Kim, SH; Kim, SM; Kim, SZ; Lee, HS; Wen, JF | 1 |
| Adamczyk, A; Azer, J; Bissell, MB; Hua, R; McBoyle, S; Robbins, C; Rose, RA; Springer, J | 1 |
1 trial(s) available for milrinone and atrial natriuretic factor
| Article | Year |
|---|---|
The use of intravenous milrinone in chronic symptomatic ischemic heart disease.
Topics: Aged; Angina Pectoris; Atrial Natriuretic Factor; Cardiotonic Agents; Coronary Disease; Drug Evaluation; Electrocardiography; Exercise Test; Female; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Norepinephrine; Phosphodiesterase Inhibitors; Pyridones | 1991 |
8 other study(ies) available for milrinone and atrial natriuretic factor
| Article | Year |
|---|---|
Cardiovascular cyclic nucleotide phosphodiesterases and their role in regulating cardiovascular function.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Atrial Natriuretic Factor; Cyclic GMP; Heart Failure; Humans; Isoenzymes; Kinetics; Milrinone; Muscle, Smooth, Vascular; Myocardial Contraction; Myocardial Infarction; Myocardium; Nitric Oxide; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyridones; Rats | 1992 |
Atrial natriuretic peptide during acute treatment of congestive heart failure.
Topics: Adult; Aged; Atrial Natriuretic Factor; Female; Heart Failure; Humans; Male; Middle Aged; Milrinone; Phosphodiesterase Inhibitors; Pyridones | 1988 |
Relaxing effects of cyclic GMP and cyclic AMP-enhancing agents on the long-lasting contraction to endothelin-1 in the porcine coronary artery.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Atrial Natriuretic Factor; Caffeine; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Colforsin; Coronary Vessels; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Endothelin-1; In Vitro Techniques; Isradipine; Milrinone; Muscle, Smooth, Vascular; Papaverine; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Purinones; Pyrrolidinones; Rolipram; Swine; Vasoactive Intestinal Peptide; Vasoconstriction; Vasodilation; Verapamil; Vinca Alkaloids | 1998 |
The effects of alpha-human atrial natriuretic peptide and milrinone on pial vessels during blood-brain barrier disruption in rabbits.
Topics: Animals; Atrial Natriuretic Factor; Blood Gas Analysis; Blood Pressure; Blood-Brain Barrier; Cerebral Veins; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Infusions, Intravenous; Male; Microcirculation; Milrinone; Rabbits; Recombinant Proteins | 2001 |
Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway.
Topics: Acetylcholine; Animals; Atrial Natriuretic Factor; Bradycardia; Calcium Channel Blockers; Carbachol; Cardiotonic Agents; Cyclic GMP; Enzyme Inhibitors; Female; Gene Expression; Guanylate Cyclase; Guinea Pigs; Heart Rate; Isoquinolines; Milrinone; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nitric Oxide; omega-Conotoxins; Phosphodiesterase Inhibitors; Polysaccharides; Receptors, Atrial Natriuretic Factor; RNA, Messenger; Sulfonamides; Synaptic Transmission; Tritium; Vagus Nerve | 2001 |
Treatment of acute heart failure: out with the old, in with the new.
Topics: Acute Disease; Atrial Natriuretic Factor; Cardiotonic Agents; Heart Failure; Humans; Milrinone; Natriuretic Peptide, Brain; Nitroglycerin; Treatment Failure | 2002 |
High and low gain switches for regulation of cAMP efflux concentration: distinct roles for particulate GC- and soluble GC-cGMP-PDE3 signaling in rabbit atria.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenine; Animals; Atrial Natriuretic Factor; Biological Transport; Cardiac Pacing, Artificial; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 2; Cyclic Nucleotide Phosphodiesterases, Type 3; Enzyme Inhibitors; Guanylate Cyclase; Heart Atria; Milrinone; Molsidomine; Myocardial Contraction; Myocytes, Cardiac; Natriuretic Peptide, C-Type; Nitric Oxide Donors; Oxadiazoles; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrazoles; Pyridines; Quinoxalines; Rabbits; Receptors, Cytoplasmic and Nuclear; Second Messenger Systems; Soluble Guanylyl Cyclase; Stroke Volume | 2004 |
The natriuretic peptides BNP and CNP increase heart rate and electrical conduction by stimulating ionic currents in the sinoatrial node and atrial myocardium following activation of guanylyl cyclase-linked natriuretic peptide receptors.
Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Atrial Function; Atrial Natriuretic Factor; Electric Conductivity; Guanylate Cyclase; Heart Atria; Heart Rate; In Vitro Techniques; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Milrinone; Myocytes, Cardiac; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Patch-Clamp Techniques; Peptide Fragments; Phosphodiesterase 3 Inhibitors; Receptors, Atrial Natriuretic Factor; Sinoatrial Node; Stimulation, Chemical; Tetrahydroisoquinolines | 2012 |